(Q46047730)

19 December 2017

title

Resveratrol attenuates angiotensin II-induced interleukin-6 expression and perivascular fibrosis (English)

1 reference

19 December 2017

author name string

Keita Inanaga

1

1 reference

19 December 2017

Toshihiro Ichiki

2

1 reference

19 December 2017

Hirohide Matsuura

3

1 reference

19 December 2017

Ryohei Miyazaki

4

1 reference

19 December 2017

Toru Hashimoto

5

1 reference

19 December 2017

Kotaro Takeda

6

1 reference

19 December 2017

Kenji Sunagawa

7

1 reference

19 December 2017

publication date

17 April 2009

1 reference

19 December 2017

published in

Hypertension Research

1 reference

19 December 2017

volume

32

1 reference

19 December 2017

issue

6

1 reference

19 December 2017

page(s)

466-471

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1038/hr.2009.47

exact match

0 references

cites work

Angiotensin receptors and their antagonists

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Angiotensin receptor blockade with candesartan attenuates atherosclerosis, plaque disruption, and macrophage accumulation within the plaque in a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Is there more than C-reactive protein and fibrinogen? The prognostic value of soluble CD40 ligand, interleukin-6 and oxidized low-density lipoprotein with respect to coronary and cerebral vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

A novel role for nuclear factor of activated T cells in receptor tyrosine kinase and G protein-coupled receptor agonist-induced vascular smooth muscle cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Cooperation of SRC-1 and p300 with NF-kappaB and CREB in angiotensin II-induced IL-6 expression in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Resveratrol: preventing properties against vascular alterations and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Critical role of cAMP-response element-binding protein for angiotensin II-induced hypertrophy of vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Long-term treatment with N(omega)-nitro-L-arginine methyl ester causes arteriosclerotic coronary lesions in endothelial nitric oxide synthase-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Role of oxidative stress in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Resveratrol inhibits angiotensin II-induced endothelin-1 gene expression and subsequent proliferation in rat aortic smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Cyclic AMP response element-binding protein mediates reactive oxygen species-induced c-fos expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Resveratrol-mediated activation of cAMP response element-binding protein through adenosine A3 receptor by Akt-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Interleukin-6 upregulates expression of KDR and stimulates proliferation of human cerebrovascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Effect of trans-resveratrol on the thrombogenicity and atherogenicity in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Resveratrol: from grapevines to mammalian biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Therapeutic potential of resveratrol: the in vivo evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappaB inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Method for the quantitative extraction of resveratrol and piceid isomers in grape berry skins. Effect of powdery mildew on the stilbene content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Plant foods and herbal sources of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Piceid, the major resveratrol derivative in grape juices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Resveratrol in raw and baked blueberries and bilberries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

C-Reactive Protein, Interleukin-6, and Fibrinogen as Predictors of Coronary Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

Angiotensin II receptor antagonists - antihypertensive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

7 January 2021

Phorbol ester and interleukin-1 induce interleukin-6 gene expression in vascular smooth muscle cells via independent pathways

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

7 January 2021

Plasma interleukin-6 and tumor necrosis factor-alpha can predict coronary endothelial dysfunction in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

7 January 2021

trans-resveratrol content in commercial peanuts and peanut products

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.47

7 January 2021

Identifiers

DOI

10.1038/HR.2009.47

1 reference

19 December 2017

1 reference

19 December 2017